Novacyt Recovers £12.2M VAT, Bolsters Cash Position

Novacyt (FR:ALNOV) has released an update.

Novacyt S.A., an international molecular diagnostics company, has successfully reclaimed £12.2 million in VAT from HMRC following a settlement with the Department of Health and Social Care, resulting in a net cash position increase of over £7.0 million. The company provides a wide range of molecular assays and instrumentation for genomic medicine, with a commercial presence in over 65 countries.

For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.